April 8, 2024
Now available JYLAMVO®
JYLAMVO® (methotrexate) is a folate analog metabolic inhibitor indicated for the:
- Treatment of adults with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen
- Treatment of adults with mycosis fungoides
- Treatment of adults with relapsed or refractory non-Hodgkin lymphoma as part of a metronomic combination regimen
- Treatment of adults with rheumatoid arthritis
- Treatment of adults with severe psoriasis
Please see full prescribing information here.
